Ethno-epidemiological study of medicinal products and medicinal plants use among pregnant women

Matta, Rosana da; Borges, Jessé Lahos; Landi, Ulisses Nilo; Barbosa, Lidiane Nunes; Lara, Amandha; Otutumi, Luciana Kazue; Ferraudo, Antônio Sérgio; Gonçalves, Daniela Dib

doi:10.37360/blacpma.21.20.1.6

Cited by 4 publications

(6 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among 111 studies, 102 studies were cross-sectional in design 27 61–161. Three studies used mixed-method approaches,162–164 and six studies had non-cross-sectional designs (ie, longitudinal and case–control),165–170 but reported cross-sectional data on HM use during pregnancy (online supplemental appendix 6).…”

Section: Resultsmentioning

confidence: 99%

Patient–physician communication on herbal medicine use during pregnancy: a systematic review and meta-analysis

Im,

Hwang,

Choi

et al. 2024

BMJ Glob Health

View full text Add to dashboard Cite

IntroductionLack of transparent communication between patients and physicians regarding the use of herbal medicine (HM) presents a major public health challenge, as inappropriate HM use poses health risks. Considering the widespread use of HM and the risk of adverse events, it is crucial for pregnant women to openly discuss their HM use with healthcare providers. Therefore, this systematic review and meta-analysis aims to estimate the pooled prevalence of pregnant women’s HM use and disclosure to healthcare providers and to examine the relationship between HM disclosure and various maternal and child health (MCH) measures.MethodsA systematic search of five databases was conducted for cross-sectional studies on HM use during pregnancy published from 2000 to 2023. Data extraction followed a standardised approach, and Stata V.16.0 was used for data analysis. Also, Spearman’s correlation coefficient was calculated to examine the association between use and disclosure of HM and various MCH indicators.ResultsThis review included 111 studies across 51 countries on the use of HM among pregnant women. Our findings showed that 34.4% of women used HM during pregnancy, driven by the perception that HM is presumably safer and more natural than conventional medical therapies. However, only 27.9% of the HM users disclosed their use to healthcare providers because they considered HM as harmless and were not prompted by the healthcare providers to discuss their self-care practices. Furthermore, a significant correlation was observed between HM disclosure and improved MCH outcomes.ConclusionInadequate communication between pregnant women and physicians on HM use highlights a deficiency in the quality of care that may be associated with unfavourable maternal outcomes. Thus, physician engagement in effective and unbiased communication about HM during antenatal care, along with evidence-based guidance on HM use, can help mitigate the potential risks associated with inappropriate HM use.

show abstract

Section: Resultsmentioning

confidence: 99%

Patient–physician communication on herbal medicine use during pregnancy: a systematic review and meta-analysis

Im,

Hwang,

Choi

et al. 2024

BMJ Glob Health

View full text Add to dashboard Cite

show abstract

“…Based on previous studies on T/CM use during pregnancy, the initial version of the questionnaire was rst developed in the English language 19,[25][26][27][28] . To ensure the content and face validity of the survey instrument, three experts (two maternal and child health experts in Korea, and one public health expert from Bolivia) reviewed the questionnaire for clarity, appropriateness, relevance, and organization.…”

Section: Survey Instrumentmentioning

confidence: 99%

Patient-physician communication on the use of traditional and complementary medicine during the COVID-19 outbreak: A cross-sectional study on pregnant women in Bolivia

Im,

Hwang,

Jung

et al. 2023

Preprint

View full text Add to dashboard Cite

During the coronavirus disease 2019 (COVID-19) pandemic, many individuals sought traditional and complementary medicine (T/CM) as an alternative to conventional healthcare, while also adhering to social distancing guidelines. Consequently, understanding the T/CM use among vulnerable populations, specifically pregnant women, and the communication practices between patients and healthcare providers regarding its use is crucial. This study assessed T/CM use among pregnant women in El Alto, Bolivia, during the COVID-19 outbreak and examined communication behaviors regarding T/CM use during antenatal consultations. A 48-item semi-structured survey was used to conduct a descriptive cross-sectional study of 271 postpartum women in two public hospitals in El Alto. Data analysis included chi-squared tests and logistic regression in SPSS ver. 26.0. Although 57% of women reported using T/CM during pregnancy, less than one-third of these women discussed their T/CM use with healthcare providers. However, over 70% of women were willing to disclose T/CM use if the discussion was initiated by healthcare providers. Potential predictors of T/CM disclosure included non-use of nutritional supplements during pregnancy and obtaining T/CM-related information from the mass media. Our findings highlight a significant communication gap between pregnant women and healthcare providers regarding T/CM use, despite their widespread use during public health crises such as COVID-19. Therefore, it is critical to develop interventions to improve communication practices and enhance the quality of care for pregnant women.

show abstract

“…According to the National Health Survey (PNS), approximately 5% of Brazilian adults use CAM, with a greater prevalence among women ( Boccolini et al, 2022 ). Furthermore, 13%–30% of pregnant women in Brazil reported using medicinal herbs, indicating a significantly higher prevalence compared to the general population ( Araújo et al, 2016 ; da Matta et al, 2021 ).…”

Section: Introductionmentioning

confidence: 99%

“…For example, Brazilian women frequently consume Peumus boldus Mol., Foeniculum vulgare Mill., and Cymbopogon citratus Stapf., despite the teratogenic and abortifacient properties of these herbs ( Araújo et al, 2016 ; Casagrande et al, 2023 ; Souza et al, 2023 ). Many women persist in using these contraindicated herbs, inadvertently endangering themselves and their babies due to simple ignorance ( da Matta et al, 2021 ). Furthermore, previous safety evaluations of Brazilian herbs are primarily based on Resolution SES/RJ No.…”

Section: Introductionmentioning

confidence: 99%

“…Furthermore, previous safety evaluations of Brazilian herbs are primarily based on Resolution SES/RJ No. 1757, which was published in 2002 ( Saúde, 2002 ; Araújo et al, 2016 ; da Matta et al, 2021 ). Considering the growing popularity of HM use among pregnant women in Brazil, it is crucial to investigate the use of HM in different regions of Brazil and assess the safety of commonly used herbs based on current scientific evidence.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Assessing the safety and use of medicinal herbs during pregnancy: a cross-sectional study in São Paulo, Brazil

Im,

Ghelman,

Portella

et al. 2023

Front. Pharmacol.

View full text Add to dashboard Cite

Background: Despite the lack of evidence supporting the safety and clinical efficacy of herbal medicine (HM), its use among pregnant women continues to increase. Given the high prevalence of contraindicated herbs among the pregnant population in Brazil, it is crucial to examine the use of HM and evaluate its safety based on the current scientific literature to ensure that women are using HM appropriately.Methods: A cross-sectional study was conducted from October 2022 to January 2023 at a public teaching hospital in São Paulo, Brazil. A total of 333 postpartum women in the postnatal wards and postnatal clinic were interviewed using a semi-structured questionnaire. The survey instrument consisted of 51 items covering the use of HM during pregnancy, sociodemographic and health-related characteristics, COVID-19 experiences, and pregnancy outcomes. For data analysis, chi-square and multivariate logistic regression were conducted using SPSS ver. 26.0.Results: Approximately 20% of respondents reported using HM during their most recent pregnancy, with a higher use observed among women from ethnic minority groups and those with prior HM experience. Among the 20 medicinal herbs identified, 40% were found to be contraindicated or recommended for use with caution during pregnancy. However, only half of the women discussed their HM use with obstetric care providers.Conclusion: This study emphasizes the continued public health concern regarding the use of contraindicated or potentially harmful HM among pregnant women in Brazil, highlighting the need for sustained efforts to reduce the risk of inappropriate HM use. By updating antenatal care guidelines based on the latest scientific evidence, healthcare providers can make informed clinical decisions and effectively monitor pregnant women’s HM use, ultimately promoting safer and more effective healthcare practices.

show abstract

Ethno-epidemiological study of medicinal products and medicinal plants use among pregnant women

Cited by 4 publications

References 18 publications

Patient–physician communication on herbal medicine use during pregnancy: a systematic review and meta-analysis

Patient–physician communication on herbal medicine use during pregnancy: a systematic review and meta-analysis

Patient-physician communication on the use of traditional and complementary medicine during the COVID-19 outbreak: A cross-sectional study on pregnant women in Bolivia

Assessing the safety and use of medicinal herbs during pregnancy: a cross-sectional study in São Paulo, Brazil

Contact Info

Product

Resources

About